Net Change in Cash
Boston Scientific Net Change in Cash decreased by 8.7% to $671.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 132.8%, from -$2.04B to $671.00M. Over 3 years (FY 2021 to FY 2025), Net Change in Cash shows an upward trend with a 107.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cashHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $645.00M | -$739.00M | $9.00M | -$1.64B | -$71.00M | $39.00M | -$363.00M | -$143.00M | $513.00M | -$77.00M | $1.44B | $565.00M | -$412.00M | -$2.04B | $314.00M | -$179.00M | $735.00M | $671.00M |
| QoQ Change | — | -214.6% | +101.2% | <-999% | +95.7% | +154.9% | <-999% | +60.6% | +458.7% | -115.0% | >999% | -60.8% | -172.9% | -396.1% | +115.4% | -157.0% | +510.6% | -8.7% |
| YoY Change | — | — | — | — | -111.0% | +105.3% | +77.9% | -101.4% | >999% | — | +497.0% | +495.1% | -180.3% | <-999% | -78.2% | -131.7% | +278.4% | +132.8% |
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Boston Scientific's net change in cash?
- Boston Scientific (BSX) reported net change in cash of $671.00M in Q4 2025.
- How has Boston Scientific's net change in cash changed year-over-year?
- Boston Scientific's net change in cash increased by 132.8% year-over-year, from -$2.04B to $671.00M.
- What is the long-term trend for Boston Scientific's net change in cash?
- Over 3 years (2021 to 2025), Boston Scientific's net change in cash has grown at a 107.3% compound annual growth rate (CAGR), from $173.00M to $1.54B.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.